Skip to content
Screener

Entrada Therapeutics TRDA Q4 2025 Annual earnings

Reported February 26, 2026 · Before market open

Revenue$1.3MMiss by $6.1M
EPS-$0.94Beat by $0.38
Revenue estimate$7.4M
EPS estimate-$1.32

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$2.1M
EPS estimate-$0.98

FAQ

When did Entrada Therapeutics report Q4 2025 earnings?
Entrada Therapeutics (TRDA) reported Q4 2025 earnings on February 26, 2026 before market open.
What were Entrada Therapeutics's Q4 2025 revenue and EPS?
Entrada Therapeutics reported revenue of $1.3M and eps of $-0.94 for Q4 2025.
Did Entrada Therapeutics beat estimates in Q4 2025?
Revenue missed the consensus estimate of $7.4M by $6.1M. EPS beat the consensus estimate of $-1.32 by $0.38.
How did Entrada Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 96.5% from $37.4M a year earlier.
Where can I find Entrada Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001689375-26-000009) and the 10-K periodic report (0001689375-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.